CDNA
Price
$11.92
Change
+$0.11 (+0.93%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
548.33M
25 days until earnings call
RDNT
Price
$57.72
Change
-$1.12 (-1.90%)
Updated
Jul 18, 02:13 PM (EDT)
Capitalization
3.55B
25 days until earnings call
Interact to see
Advertisement

CDNA vs RDNT

Header iconCDNA vs RDNT Comparison
Open Charts CDNA vs RDNTBanner chart's image
CareDx
Price$11.92
Change+$0.11 (+0.93%)
Volume$27.29K
Capitalization548.33M
RadNet
Price$57.72
Change-$1.12 (-1.90%)
Volume$143
Capitalization3.55B
CDNA vs RDNT Comparison Chart in %
Loading...
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDNA vs. RDNT commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDNA is a Hold and RDNT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (CDNA: $11.81 vs. RDNT: $58.84)
Brand notoriety: CDNA and RDNT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CDNA: 1169% vs. RDNT: 171%
Market capitalization -- CDNA: $548.33M vs. RDNT: $3.55B
CDNA [@Medical Specialties] is valued at $548.33M. RDNT’s [@Medical Specialties] market capitalization is $3.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDNA’s FA Score shows that 0 FA rating(s) are green whileRDNT’s FA Score has 1 green FA rating(s).

  • CDNA’s FA Score: 0 green, 5 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, RDNT is a better buy in the long-term than CDNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDNA’s TA Score shows that 5 TA indicator(s) are bullish while RDNT’s TA Score has 4 bullish TA indicator(s).

  • CDNA’s TA Score: 5 bullish, 4 bearish.
  • RDNT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CDNA is a better buy in the short-term than RDNT.

Price Growth

CDNA (@Medical Specialties) experienced а -42.75% price change this week, while RDNT (@Medical Specialties) price change was +2.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.65%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -2.13%.

Reported Earning Dates

CDNA is expected to report earnings on Oct 30, 2025.

RDNT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Specialties (-0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDNT($3.55B) has a higher market cap than CDNA($548M). RDNT YTD gains are higher at: -15.750 vs. CDNA (-44.839). RDNT has higher annual earnings (EBITDA): 293M vs. CDNA (-84.92M). RDNT has more cash in the bank: 343M vs. CDNA (235M). CDNA has less debt than RDNT: CDNA (34.2M) vs RDNT (1.49B). RDNT has higher revenues than CDNA: RDNT (1.62B) vs CDNA (280M).
CDNARDNTCDNA / RDNT
Capitalization548M3.55B15%
EBITDA-84.92M293M-29%
Gain YTD-44.839-15.750285%
P/E RatioN/A962.00-
Revenue280M1.62B17%
Total Cash235M343M69%
Total Debt34.2M1.49B2%
FUNDAMENTALS RATINGS
CDNA vs RDNT: Fundamental Ratings
CDNA
RDNT
OUTLOOK RATING
1..100
5281
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
10039
SMR RATING
1..100
4690
PRICE GROWTH RATING
1..100
5756
P/E GROWTH RATING
1..100
962
SEASONALITY SCORE
1..100
5047

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDNA's Valuation (96) in the Medical Specialties industry is in the same range as RDNT (96) in the Medical Or Nursing Services industry. This means that CDNA’s stock grew similarly to RDNT’s over the last 12 months.

RDNT's Profit vs Risk Rating (39) in the Medical Or Nursing Services industry is somewhat better than the same rating for CDNA (100) in the Medical Specialties industry. This means that RDNT’s stock grew somewhat faster than CDNA’s over the last 12 months.

CDNA's SMR Rating (46) in the Medical Specialties industry is somewhat better than the same rating for RDNT (90) in the Medical Or Nursing Services industry. This means that CDNA’s stock grew somewhat faster than RDNT’s over the last 12 months.

RDNT's Price Growth Rating (56) in the Medical Or Nursing Services industry is in the same range as CDNA (57) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to CDNA’s over the last 12 months.

RDNT's P/E Growth Rating (2) in the Medical Or Nursing Services industry is significantly better than the same rating for CDNA (96) in the Medical Specialties industry. This means that RDNT’s stock grew significantly faster than CDNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDNARDNT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIESX26.67N/A
N/A
Calvert International Equity R6
GABTX24.30N/A
N/A
Gabelli Global Content & Connect AAA
GSIKX20.47N/A
N/A
Goldman Sachs International Eq Inc Instl
GQGPX17.22N/A
N/A
GQG Partners Emerging Markets Equity Inv
SPMJX5.79N/A
N/A
Invesco SteelPath MLP Alpha Plus R

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
+2.76%
ITGR - RDNT
50%
Loosely correlated
-2.13%
GKOS - RDNT
48%
Loosely correlated
+0.51%
NNOX - RDNT
47%
Loosely correlated
+1.60%
TWST - RDNT
47%
Loosely correlated
-2.29%
NTRA - RDNT
47%
Loosely correlated
-3.38%
More